Haptoglobin polymorphism in relation to antioxidative enzymes activity in type 2 diabetes mellitus

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 7, Issue 1, 2013, Pages 26-31

  Awadallah, Samir M ^a   Ramadan, Ahmad R ^b   Nusier, Mohamad K ^c  

^a UNIVERSITY OF SHARJAH   (United Arab Emirates)

^b ARABIAN GULF UNIVERSITY   (Bahrain)

^c JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Antioxidative enzymes; Ceruloplasmin; Haptoglobin; Oxidative stress; Type 2 diabetes mellitus

Indexed keywords

CATALASE; CERULOPLASMIN; GLUCOSE; GLUTATHIONE PEROXIDASE; HAPTOGLOBIN; HEMOGLOBIN A1C; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CERULOPLASMIN BLOOD LEVEL; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM;

BIOLOGICAL MARKERS; CATALASE; CERULOPLASMIN; DIABETES MELLITUS, TYPE 2; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GLUTATHIONE PEROXIDASE; HAPTOGLOBINS; HUMANS; INDIA; INFLAMMATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; SPECTROPHOTOMETRY; SUPEROXIDE DISMUTASE;

EID: 84875371433     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2013.02.024     Document Type: Article

References (46)

1. M. Valko, D. Leibfritz, J. Moncol, M.T.D. Cronin, M. Mazur, and J. Telser Free radicals and antioxidants in normal physiological functions and human disease International Journal of Biochemistry and Cell Biology 39 2007 44 84
2. F. Giacco, and M. Brownlee Oxidative stress diabetic complications Circulation Research 107 2010 1058 1070
3. M. Brownlee The pathobiology of diabetic complications: a unifying mechanism Diabetes 54 2005 1615 1625
4. D. Guigliano, A. Ceriello, and G. Paolisso Oxidative stress and diabetic vascular complications Diabetes Care 19 1996 257 267
5. D. Niedowicz, and D. Daleke The role of oxidative stress in diabetic complications Cell Biochemistry and Biophysics 43 2005 289 330
6. A.C. Maritim, R.A. Sanders, and J.B. Watkins Diabetes, oxidative stress, and antioxidants: a review Journal of Biochemical and Molecular Toxicology 17 2003 24 38
7. A. Likidlilid, N. Patchanans, T. Peerapatdit, and C. Sriratanasathavorn Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients Journal of the Medical Association of Thailand 93 2010 682 693
8. P. Pasupathi, J. Farook, and P. Chinnaswamy Oxidant-antioxidant status, high sensitive C-reactive protein and homo cysteine levels in type 2 diabetic patients with and without microalbuminuria International Journal of Biological and Medical Research 1 2010 04 08
9. F.N. Ahmed, F.N. Naqvi, and F. Shafiq Lipid peroxidation and serum antioxidant enzymes in patients with type 2 diabetes mellitus Annals of the New York Academy of Sciences 1084 2006 481 489
10. K. Komosinska-Vassev, K. Olczyk, P. Olczyk, and K. Winsz-Szczotka Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients Diabetes Research and Clinical Practice 68 2005 207 216
11. K. Kaviarasana, M.M. Arjunanb, and K.V. Pugalendi Lipid profile, oxidant-antioxidant status and glycoprotein components in hyperlipidemic patients with/without diabetes Clinica Chimica Acta 362 2005 49 56
12. R. Memisogullari, S. Tays, E. Bakan, and I. Capoglu Antioxidant status and lipid peroxidation in type II diabetes mellitus Cell Biochemistry and Function 21 2003 291 296
13. S. Bhatiaa, R. Shukla, S. Venkata Madhub, J. Kaur Gambhira, and K. Madhava Prabhua Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy Clinical Biochemistry 36 2003 557 562
14. H.M. Turk, A. Sevinc, and C. Camci Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus Acta Diabetologica 39 2002 117 122
15. M.M. Kesavulu, B.K. Rao, R. Giri, J. Vijaya, G. Subramanyam, and C. Apparao Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease Diabetes Research and Clinical Practice 53 2001 33 39
16. M.M. Kesavulu, R. Giri, B.K. Rao, and C. Apparao Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications Diabetes & Metabolism 26 2000 387 392
17. K.Z. Kedziora-Kornatowska, M. Luciak, J. Blaszczyk, and W. Pawlak Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non-insulin dependent diabetes with or without diabetic nephropathy Nephrology, Dialysis, Transplantation 13 1998 2829 2832
18. R.K. Sundaram, A. Bhaskar, S. Vijayalingam, M. Viswanathan, R. Mohan, and K.R. Shanmugasundaram Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications Clinical Science (London) 90 1996 255 260
19. A.F. Jones, J.W. Winkles, P.E. Jennings, C.M. Florkowski, J. Lunec, and A.H. Barnett Serum antioxidant activity in diabetes mellitus Diabetes Research 7 1988 89 92
20. M.R. Langlois, and J.R. Delanghe Biological and clinical significance of haptoglobin polymorphism in humans Clinical Chemistry 42 1996 1589 1600
21. S.M. Sadrzadeh, E. Graf, S.S. Panter, P.E. Hallaway, and J.W. Eaton Hemoglobin. A biologic Fenton reagent Journal of Biological Chemistry 259 1984 14354 14356
22. M. Kristiansen, J.H. Graversen, and C. Jacobsen Identification of the hemoglobin scavenger receptor Nature 409 2001 198 201
23. V.V. Bamm, V.A. Tsemakhovich, M. Shaklai, and N. Shaklai Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL Biochemistry 43 2004 3899 3906
24. M. Melamed-Frank, O. Lache, and B.I. Enav Structure/function analysis of the antioxidant properties of haptoglobin Blood 98 2001 3693 3698
25. R. Asleh, S. Marsh, and M. Shiltruck Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease Circulation Research 92 2003 1193 1200
26. R. Asleh, J. Guetta, S. Kalet-Litman, R. Miller-Lotan, and A.P. Levy Haptoglobin genotype and diabetes dependent differences in iron mediated oxidative stress in vitro and in vivo Circulation Research 96 2005 435 441
27. J.R. Delanghe, M.R. Langlois, M.L. De Buyzere, M.A. Torck, and Vitamin C deficiency and scurvy are not only a dietary problem but are codetermined by the haptoglobin polymorphism Clinical Chemistry 53 2007 1397 1400
28. A. Brouwers, M. Langlois, and J. Delanghe Oxidized low-density lipoprotein, iron stores, and haptoglobin polymorphism Atherosclerosis 176 2004 189 195
29. P.R. Moreno, K.R. Purushothaman, and M. Purushothaman Haptoglobin genotype is a major determinant of the amount of iron in the human atherosclerotic plaque Journal of the American College of Cardiology 52 2008 1049 1051
30. M. Suleiman, R. Asleh, and Z. Cabantchik Serum chelatable redox-active iron is an independent predictor of mortality after myocardial infarction in individuals with diabetes mellitus Diabetes Care 27 2004 2730 2732
31. A.P. Levy Application of pharmacogenomics in the prevention of diabetic cardiovascular disease: mechanistic basis and clinical evidence for utilization of the haptoglobin genotype in determining benefit from antioxidant therapy Pharmacology & Therapeutics 112 2006 501 512
32. M. Vardi, S. Blum, and A.P. Levy Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus-natural history of the disease and the effect of vitamin E treatment, meta-analysis of the medical literature European Journal of Internal Medicine 23 2012 628 632
33. R. Asleh, and A.P. Levy In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease Vascular Health and Risk Management 1 2005 19 28
34. E. Szaleczky, J. Prechl, J. Fehér, and A. Somogyi Alterations in enzymatic antioxidant defence in diabetes mellitus-a rational approach Postgraduate Medical Journal 75 1999 13 17
35. G. Floris, R. Medda, A. Padiglia, and G. Musci The physiopathological significance of caeruloplasmin Biochemical Pharmacology 60 2000 1735 1741
36. H. Schosinsky, H.P. Lehman, and M.F. Beeler Measurement of ceruloplasmin from its ferroxidase activity in serum by use of O-dianisidine-dihydrochloride Clinical Chemistry 20 1974 1556 1563
37. H. Aebi Catalase in vitro Methods in Enzymology 105 1984 121 126
38. M. Hamad, and S. Awadallah Age group-associated variations in Hp type distribution in Jordanians Clinica Chimica Acta 300 2000 75 81
39. K. Arali, S. Lizuka, Y. Tada, K. Oikawa, and N. Taniguchi Increase in glycosylated form of erythrocyte superoxide dismutase in diabetes and close association of the nonenzymatic glycosylation with the enzyme activity Biochimica et Biophysica Acta 924 1987 292 296
40. C.H. Jung, W.J. Lee, and J.H. Yu Elevated serum ceruloplasmin levels are associated with albuminuria in Korean men with type 2 diabetes mellitus Diabetes Research and Clinical Practice 94 2011 e3 e7
41. V.M. Samokyszyn, D. Miller, D. Reif, and S. Aust Inhibition of superoxide and ferritin dependent lipid peroxidation by ceruloplasmin Journal of Biological Chemistry 264 1989 21 26
42. V.M. Samokyszyn, D.W. Reif, D.M. Miller, and S.D. Aust Effects of ceruloplasmin on superoxide-dependent iron release from ferritin and lipid peroxidation Free Radical Research Communications 1 1991 153 159
43. Z.K. Attieh, C.K. Mukhopadhyay, V. Seshadri, N.A. Tripoulas, and P.L. Fox Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism Journal of Biological Chemistry 274 1999 1116 1123
44. A. Van Campenhout, C.M. Van Campenhout, A.R. Lagrou, and B. Manuel-y-Keenoy Transferrin modifications and lipid peroxidation: implications in diabetes mellitus Free Radical Research 37 2003 1069 1077
45. A. Van Campenhout, C. Van Campenhout, A.R. Lagrou, G. Moorkens, C. De Block, and B. Manuel-y-Keenoy Iron-binding antioxidant capacity is impaired in diabetes mellitus Free Radical Biology and Medicine 40 2006 1749 1755
46. P.M. Gueye, N. Glasser, G. Ferard, and J.M. Lessinger Influence of human haptoglobin polymorphism on oxidative stress induced by free hemoglobin on red blood cells Clinical Chemistry and Laboratory Medicine 44 2006 542 547